GlassScriptPhysician profile
Anthony D Oberle
NPI 1487033817
$2,110.08
in general payments reported to CMS, 2019-2025
22 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.45 · 2020: $165 · 2021: $664 · 2022: $685 · 2023: $210 · 2024: $108 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $533.27 | 2019-2021 | |
| Palette Life Sciences, INC. | $488.57 | 2021-2022 | |
| Axonics, INC. | $199.18 | 2022 | |
| Teleflex LLC | $133.25 | 2021 | |
| Dendreon Pharmaceuticals LLC | $114.38 | 2022-2023 | Provenge |
| Verity Pharmaceuticals INC. | $95.83 | 2022-2023 | Trelstar |
| Sumitomo Pharma America, INC. | $81.84 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $59.57 | 2024-2025 | Erleada |
| Immunitybio, INC. | $59.46 | 2025 | |
| Endo Pharmaceuticals INC. | $51.27 | 2021-2023 | Xiaflex, Aveed |
| Abbvie INC. | $43.75 | 2024-2025 | |
| Urogen Pharma, INC. | $38.81 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $36.21 | 2023-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $27.39 | 2022-2024 | Keytruda |
| Calyxo, INC. | $25.34 | 2025 | Cvac Aspiration System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.01 | 2022 | |
| 180 Medical, INC. | $18.82 | 2021 | |
| Valencia Technologies Corporation | $17.09 | 2025 | Ecoin Device Kit |
| Laborie Medical Technologies Corp. | $16.75 | 2024 | Urgent PC Neuromodulation System |
| Olympus America INC. | $15.75 | 2023 | Itind System |
| Myriad Genetic Laboratories, INC. | $15.00 | 2023 | Prolaris |
| Myovant Sciences INC. | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Oberle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.